A Study of Pexa-Vec (JX-594) Prior to Sorafenib to Treat Unresectable Primary Hepatocellular Carcinoma
NCT01171651
Adenocarcinoma, Carcinoma
Busan, South Korea
View Trial DetailsNCT Number: NCT01237132
The current treatment guidelines of hepatocellular carcinoma (HCC) of the American and European Associations for the Study of Liver Disease are based on the Barcelona-Clinic-Liver-Cancer classification (BCLC), which does not recommend surgery in patients with large, multinodular and macrovascular invasive disease. The aim of this study was to investigate the role of hepatic resection in a large retrospective multicentric cohort of patients resected for HCC regardless of the BCLC indications.
Looking for future studies?
Notify MeAll sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The primary endpoint of the study was the overall survival of patients resected for HCC in any stage of the BCLC classification.
The secondary endpoint was the disease-free survival of patients resected for HCC among the BCLC stages.
University of Milan
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01171651
Adenocarcinoma, Carcinoma
Busan, South Korea
View Trial DetailsNCT04962958
Adenocarcinoma, Antimetabolites
Guangzhou, Guangdong, China
View Trial DetailsNCT04102098
Adenocarcinoma, Carcinoma
Los Angeles, California, United States
View Trial DetailsNCT00554372
Adenocarcinoma, Carcinoma
La Jolla, California, United States
View Trial Details